Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy.

van Steensel L, van Hagen PM, Paridaens D, Kuijpers RW, van den Bosch WA, Drexhage HA, Hooijkaas H, Dik WA

Open source

DOI
10.1136/bjo.2010.192302
Published
2011 May
Container
The British journal of ophthalmology
Publisher
Not recorded
Open access
no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1136/bjo.2010.192302,
  title = {Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy.},
  author = {van Steensel L and van Hagen PM and Paridaens D and Kuijpers RW and van den Bosch WA and Drexhage HA and Hooijkaas H and Dik WA},
  year = {2011},
  journal = {The British journal of ophthalmology},
  doi = {10.1136/bjo.2010.192302},
  url = {https://doi.org/10.1136/bjo.2010.192302}
}

RIS

TY  - JOUR
TI  - Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy.
AU  - van Steensel L
AU  - van Hagen PM
AU  - Paridaens D
AU  - Kuijpers RW
AU  - van den Bosch WA
AU  - Drexhage HA
AU  - Hooijkaas H
AU  - Dik WA
PY  - 2011
JO  - The British journal of ophthalmology
DO  - 10.1136/bjo.2010.192302
UR  - https://doi.org/10.1136/bjo.2010.192302
ER  - 

APA

L, V. S., PM, V. H., D, P., RW, K., WA, V. D. B., HA, D., H, H., & WA, D. (2011). Whole orbital tissue culture identifies imatinib mesylate and adalimumab as potential therapeutics for Graves' ophthalmopathy.. The British journal of ophthalmology. https://doi.org/10.1136/bjo.2010.192302

Source records